Rowan University
HYBRID LIPID-GOLD NANOPARTICLES DESIGNED FOR SIMULTANEOUS GENE THERAPY AND PHOTOTHERMAL THERAPY AGAINST CANCER
Abstract
dc:description.abstractTraditional cancer treatments such as chemotherapy and surgery include adverse side effects and acquire resistance. Here, I developed a novel hybrid lipid-gold nanoparticle technology (LGNP) to achieve simultaneous gene regulation and photothermal therapy, specifically targeting pediatric acute myeloid leukemia (AML) and ovarian cancer. This core material consists of slice core/gold nanoshells, which are efficient heat transducers where NIR light activates nanoshells embedded in tumors, generating localized heat for tumor ablation. The ionizable lipid coating facilitates intracellular delivery of nucleic acids, such as mRNA or siRNA, to modulate gene expression effectively. Lipid-gold hybrid nanoparticles (LGNPs) are synthesized via a controlled self-assembly process, incorporating a lipid layer with polyethylene glycol (PEG) linkers. We optimized LGNP formulations by varying PEG molar ratios to enhance mRNA delivery by evaluating LGNP uptake and transfection in Kasumi-1 (pediatric AML) and OVCAR-3 (ovarian cancer) cell lines. Further, LGNPs facilitated efficient mRNA delivery, yielding a 700-fold increase in luminescence in Kasumi-1 AML cells and a 6000-fold increase in OVCAR-3 ovarian cancer cells compared to controls.
Degree
thesis:*- Name thesis:degree_name
- M.S. Biomedical Engineering
- Level thesis:degree_level
- Thesis
- Discipline thesis:degree_discipline
- Biomedical Engineering
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Devaguptapu, Navya sree
- Contributors dc:contributor
-
- Rachel Riley, Ph.D.
- Vincent Beachley, Ph.D.
- Erik Brewer, Ph.D.
Subjects
dc:subject × 1Identifiers
dc:identifier.*- Repository record dc:identifier
- https://rdw.rowan.edu/etd/3550